micronization of astaxanthin by the supercritical anti …...micronization of astaxanthin by the...
TRANSCRIPT
Micronization of astaxanthin by the supercritical anti-
solvent process (SAS)
Joana Jorge da Costa Dep. Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Portugal
*Corresponding author: [email protected]
Abstract This aim of this work was the micronization of synthetic astaxanthin at 98.6% purity by
supercritical antisolvent technique (SAS). The objectives were accomplished using CO2 as
antisolvent and THF as solvent. Doe was applied in a fractional factorial design at 4 factors,
pressure (100 to 150 bar), concentration (0.5-3 bar), temperature (40-60°C) and solution flow rate
(0.5-1.5 ml/min) and at 2 responses (yield of micronized product and mean particle size.
Screening analysis showed higher significance to pressure, concentration, and temperature. 2
experiments were run to have a better understanding of the temperature influence, it showed that
it influences morphologies of micronized particles, and that at increasing temperature, sphere like
and smaller particles were obtained. Central Composite Design was studied for optimization
process. Factors for this analyse was pressure (100-150 bar) and concentration (1-3 mg/ml) and
mean particle size for the response. Temperature and flow rate were maintained respectively at
60° C and1.5ml/min. Minimum mean particle size obtained was of 0.182 nm during the screening
process at 100 bar, 60° C, 0.5ml/min and 3 mg/ml. Central composite design predicted that a
similar response could be obtained at flow rate of 1.5 ml/min but the mean particle size found in
this conditions was a little higher, 0.202 nm.
Introduction Astaxanthin is a red carotenoid from the
carotenoid family. The most common source
of Astaxanthin is the microalgae
Haematoccus pluvialis, which can synthetize
large amounts of this carotenoid in order to
protect itself from ultraviolet radiation and in
response to nutrient and environmental
stress. Astaxanthin started to be applied in
coloring salmonid fish in the feed industry,
but is currently used in health and well-being
markets, due to its anti-oxidant properties,
as well as in in cosmetics (Guedes et al.,
2011). Studies have shown that this
compound is not only a super antioxidant,
but it possesses anti-inflammatory
properties. This carotenoid appears to have
potential benefits for acid reflux and macular
degeneration, provides vascular benefits,
and less oxidative stress and inflammation.
Moreover, astaxanthin enhances and
strengthens the immune system and
decreases DNA damage (Anarjan and Tan,
2013, Guerin et al., 2003, Hussein et al.,
2006, Vílchez et al., 2011). Fasset and
Coombes, (2011) reported that the regular
ingestion of astaxanthin may improve
oxidative response and prevent tissue
damage. Also, astaxanthin proved to be a
very good protective agent to membranous
phospholipids and other lipids against
peroxidation (Naguib, 2000 and Guerin et
al., 2003).
In the pharmaceutical industry smaller
particle sizes can increase the efficiency of
drug uptake by cells, which can mean the
need of lower doses and the consequent
reduce cost of the medicine. The size of solid
particles of an active pharmaceutical
ingredient used in a pharmaceutical
formulation can have a great impact in
properties like solubility, dissolution rate,
dosage levels and bioavailability.
Particle design is an area of most
importance since it can be determinant in the
efficiency of absorption, solubility and
diffusion of a solid compound. Particles can
be designed using traditional micronization
techniques or supercritical and compressed
gas based micronization techniques.
Micronization is the general term used to
describe numerous processes that aim to
reduce the average diameter of solid
material particles. Usually, micronization is
referred to the creation of particles with
diameters in the order of 10 µm, however,
due the development of modern techniques
as well as the demand of pharmaceutical
industry, it is now also used to describe the
formation of particles with nano- sized
diameters.
The most common micronization techniques
are spray drying, mechanical comminution,
solute recrystallization, freeze drying, and
interfacial polymerization. Nevertheless,
these techniques presented significant
disadvantages, such as excessive use of
solvent, thermal and chemical solute
degradation, high residual solvent
concentration, and difficulty in controlling the
particle size, particles size distribution as
well as, changing the crystal structure of the
precipitated powder.
To overcome those disadvantages
micronization techniques relying on
supercritical fluids technology were
developed. In the SAS process (Figure1),
the supercritical fluid acts as anti-solvent,
and the substrate is dissolved into a liquid
solvent (solution). The supercritical anti-
solvent is continuously fed to the
precipitation vessel (PV), as well as the
liquid solution, which is sprayed through a
restrictor into the PV.
Figure 1: Schematic representation of a SAS micronization apparatus. S1: CO2 supply; S2: liquid supply; RB: refrigerating bath; P1, P2: pumps; TC: thermocouple; M: manometer; PV: precipitation vessel; MV: micrometering valve; LS: liquid separator; BPV: back pressure valve; R: rotameter; DM: dry-test meter (De Marco and Reverchon 2011).
The rapid contact between the two media
causes the precipitation of the solute, which
is mediated by solubility interactions
between the supercritical fluid and the liquid
solvent. After precipitation the fluid phase is
expanded through a micrometric valve (MV),
and the liquid solvent is recovered in the low-
pressure liquid solvent recovery vessel (LS).
Furthermore, the antisolvent is expanded to
atmospheric pressure. During the
supercritical antisolvent process the surface
area will be increased, which leads to an
improvement in bioavailability. This fact is of
great importance in drug delivery since
narrower particle size distribution means a
better flexibility of administration. Moreover
increasing the bioavailability the required
drug dosage decreases and raises the
control over a sustained period (Acosta,
2009).
Materials and Methods
Astaxanthin was obtained from Dr.
Ehrenstorfer GmbH (98,6%).
Tetrahydrofuran (p.a grade) was purchase
from Sigma-Aldrich and CO2 was provided
from air liquid (99.998%). Solubility tests were carried in ethanol,
acetone, ethyl acetate, DMSO,
tetrahydrophuran and dichloromethane.
Experimental procedure consisted in
dissolving 10mg of astaxanthin in a volume
of 1 ml of organic solvent. Subsequent
additions of 1ml were made until it was
observed that no more solid could be
dissolve. The suspension was then stirred
for 30 minutes, to ensure that saturation of
the solution was reached. Afterwards,
samples of 2ml were taken from the solution,
spectrophotometry (Hitachi-2000) to
determine the concentration of the dissolved
fraction. Absorption spectra were run
between 380 and 700 nm and the
concentration of astaxanthin in the solvent
was determined using the Beer-Lambert
law, considering the maximum absorbance
of the solution and the specific optical
coefficient at the wavelength of the
maximum absorbance of astaxanthin in the
solvent (Delia B. Rodriguez-Amaya, Ph.D;,
2001)
SAS experimental studies were conducted
in apparatus constructed at IST, under
orientation of Dra Beatriz Nobre and
Professor António Palavra at IST (Instituto
Superior Técnico).
The experimental procedure was the
following: after reaching the target pressure,
by pumping CO2, a previous calculated
amount of organic solvent is injected into this
vessel to ensure that all the operation will be
carried out in steady state. When the organic
solvent concentration inside the vessel
reaches the fed concentration, the
micrometering valve, MV, is regulated to
establish the flow rate at the exit (bottom) of
the precipitation vessel and it is given some
time for the system to stabilize. In that point,
the solution is injected and the micronization
takes place. At the end of the solution
injection, SC-CO2 will pass through the
precipitation vessel in order to remove all
existing organic solvent. The washing time
with pure SC-CO2 is approximately 75 min.
The morphology of unprocessed and
processed particles was assessed using
SEM (CamScan MV 2300, England).
Particles of the several samples were coated
with gold–palladium at room temperature
before the examination. The accelerator
voltage for scanning was 25.0 kV.
ImageJ software was used to analyze SEM
photomicrographs, considering the ferret
diameter as the measure of the particle size.
Malvern Mastersizer Hydro 2000, Beckman
Coulter Multisizer 4 or Nano Particle
Tracking Analysis (NTA, from Nanosight)
were also used to determine the mean
particle size and size distribution of the
processed astaxanthin.
HPLC analysis was used to evaluate the
purity and presence of degradation
compounds of the obtained micronized
powder, as well as to determine the
concentration of astaxanthin in the solution
(organic solvent and supercritical CO2)
leaving the precipitation vessel.
Design of experiments has been employed
in many areas of investigation in order to
maximize the efficiency of scientific work and
minimize waste and cost. It allows a smarter
choice of experiments that give the most
information possible with the fewest
experiments (Hibbert, 2012).
Fractional factorial design (FFD) is usually
use as a screening method to determine the
significant effects, since it allows obtain the
main effects model with a minimum number
of experiments. Using the responses
obtained by the experimental work a factorial
model is then constructed through a list of
coefficients multiplied by associated factor
levels. This model is in the form of presented
by equation 1.
𝑌 = 𝛽0 + 𝛽1𝐴 + 𝛽2𝐵 + 𝛽3𝐶 + 𝛽4𝐷 +
𝛽12𝐴𝐵 + 𝛽13𝐴𝐶 + ⋯ (Eq 1)
Where β, is the coefficient associated with
factor n, and the letters, A, B, C, D, represent
the factors in the model. Combinations of
factors, such as AB, represent an interaction
between the individual factors in the term.
Anova tests are then run by Design-Expert
9.0.3. The results given, allow to determine
significance of the model, lack of fit and the
weight that each factor has in the model
construction. The first parameter is
determined by R-squared value and the
other two by p-value.
After determined the factors with higher
importance by FFD a central composite
design (CCD) can be run. In this stage
another matrix of experiments is generated,
response values are introduced in the matrix
and Anova results predict once again the
new model, by a similar equation. Having a
significant model and well-adjusted it is
possible to run space design to find the
response that meet our goal. CCD generates
a series of new experiments to obtain similar
responses at different factors levels. Those
experiences can be run and new values can
be introduced, so the model can be adjust or
confirmed.
Results and Discussion
THF was the only solvent that returned a
significant amount of micronized powder,
and is a class 2 solvent, regulated to be used
in food industry, it was chosen as the organic
solvent for the astaxanthin SAS
micronization experimental studies.
FFD with 4 factors, and 2 responses was
built. The range selected for each effective
factor was carefully chosen: 40 to 60º C for
temperature, 100 to 150 bar for pressure, 1.0
to 1.5 for
CO2/organic solution flow rate ratio and 0.15
to 3 mg/ml for solution concentration. Two
response factors were chosen as the most
important criteria to optimize the SAS
micronization of astaxanthin, and these were
the mean particle size and the yield of the
process (which was defined as the ratio of
the amount of micronized astaxanthin
collected in the precipitation vessel and the
amount of astaxanthin in the organic
solution). The total matrix design showed 12
runs and is described in table 1. Experiments
were carried out by the order of table 1.
The analysis of variance (ANOVA) results
was carried out to assess the main effects.
Table 2 summarizes Anova for mean particle
size analysis, being considered that factors
with p-value below 0.05 have significant
effect. Negative values on Stdized effect
means an inverse proportionality between
factor and response.
Thus the final Equation in Terms of Factors
for mean particle size (MPS) analysis is the
following (equation 2): MPS = −28.87558 + 0.36608 × Pressure + 0.10818 ×
Temperature + 2.35828 × Flow + 4.91990 ×
Concentration − 2.28790 ×
〖10〗^(−3) × Pressure × Temperature − 0.021522 ×
Pressure × Flow − 0.052027 × Pressure ×
Concentration (Eq.2).
Run Pressure
(bar)
Temperat
ure (°C)
Astaxanthin
Concentration
(mg/ml)
Solution
Flow
(ml/min)
Yield of
micronization
(%)
Mean Particle
Size (µm)
Std.
Dev.
1 125 50 1.575 1 77.2 4.165 13.083
2 100 40 0.15 0.5 62.9 3.401 5.303
3 150 40 0.15 1.5 33.0 15.337 10.103
4 125 50 1.575 1 77.2 4.764 20.146
5 125 50 1.575 1 86.0 3.361 15.921
6 100 60 0.15 1.5 49.3 1.194 44.077
7 150 60 0.15 0.5 7.3 0.193 0.105
8 100 60 3 0.5 68.7 0.182 7.221
9 125 50 1.575 1 85.71 5.547 13.475
10 150 40 3 0.5 78.4 7.980 9.374
11 100 40 3 1.5 80.5 2.800 7.636
12 150 60 3 1.5 87.6 2.415 82.654
Term df Stdized Effect Sum of Squares
% Contribution F Value p-value
Model 7 206.656 19.541 0.006
A-Pressure 1 7.408 109.767 51.607 72.655 0.001
B-Temperature 1 - 3.553 25.253 11.872 16.715 0.015
C-Flow 1 - 0.335 0.224 0.105 0.148 0.720
D-Concentration 1 - 4.510 40.686 19.129 26.930 0.007
AB 1 - 1.147 2.630 1.236 1.741 0.258
AC 1 - 0.535 0.573 0.269 0.379 0.571
AD 1 - 3.710 27.523 12.940 18.218 0.013
Residual 4 6.043
Lack of Fit 1 3.487 4.093 0.136
Pure Error 3 2.556
Cor Total 11 212.699
Table 2: Anova results for mean particle size analysis.
Table 1: Matrix for FFD at 4 factors (Pressure, Temperature, Astaxanthin Concentration of organic solution and Solution Flow Rate) and 2 responses (Yield of Micronization and Mean Particle Size)
created by Design- Expert 9.0.3. Std. Dev. values stands for mean particle size analysis
Considering now the yield analysis, the
given model had a significant curvature
(centre points in-formation) p-value, which
means that the design should be augmented
via Design Tools to add runs that can
estimate quadratic terms. Problems with
curvature result in different estimations for
adjusted and not adjusted models and the
model may not be appropriate for prediction.
Standard deviation was 19.33 and R-
Squared was 0.77. Even if the model
obtained (Adjusted) is not appropriate for
prediction it can be used to make good
diagnostics. Through p-value observation it
seems that the main effect that influences
the response yield, in the micronization
process, is the concentration followed by the
pressure.
Taking in account the results of FFD
screening test study, to continue the
optimization, two variables were fixed at
suitable amounts (temperature of 60ºC and
flow rate ratio of 10) and a central composite
design with 2 factors (Pressure and organic
solution concentration) and one response
(Mean Particle Size) was created. The
obtained matrix was generated and
randomized by Design-Expert 9.0.3, and is
presented in table 3 with the respective
values of the obtained response and
standard deviation of the particle size
analyses. Note that value fixed for the
temperature was chosen taking into account
the morphology and mean particle size
results obtained with FFD. In fact, it was
possible to observe from SEM images that
the morphology the micronized astaxanthin
changed from long needles to small spheres
(Figure 2) when the temperature rose from
40 to 60ºC. Also, the mean particle size and
particle size distribution for the experiment
carried out at 60ºC, 150 bar, 0.5 ml/min
organic solution flow rate and 0.15 g/ml of
organic solution concentration, was
significantly smaller and narrow,
respectively, than the results obtained at
40ºC. In order to confirm the selection of
Run Pressure
(bar)
Astaxanthin Concentration
(mg/ml)
Mean Particle
Size (µm)
Std. Dev.
1 100 1 3.192 1.173
2 125 3 1.338 18.782
3 100 2 0.619 0.985
4 125 1 78.446 92.622
5 125 2 48.623 44.895
6 150 2 58.283 92.00
7 100 3 0.202 0.122
8 125 2 49.384 49.384
9 125 2 38.623 40.405
10 150 1 218.578 248.947
11 150 3 60.037 79.781
12 125 2 35.916 40.405
13 125 2 52.976 36.814
14 125 1 94.135 101.884
Figure 2: SEM images of SAS at (A) 40ºC, 100 bar, 3mg/ml and 0.15 ml/min and experience (B) 60ºC, 100 bar 3mg7ml and 1.5 ml/min
B A
Table 3: CCD matrix obtained by Design- Expert 9.0.3 at 2 factors ( Pressure and Astaxanthin Concentration)
and one response ( Mean Particle Size). Std. Dev. stands for the Mean Particle Size determination.
temperature two experiments were carried
out at the following conditions. 40ºC, 100 bar
3mg/ml, 0.15 ml/min and 60ºC, 100 bar, 3
mg/ml, 1.5 ml/min. SEM analysis of the
micronized powder (figure 10) showed that
the experiment carried out at 60ºC lead to
small spheres with mean particle size of
1.354 µm and particle size distribution of
0.013 – 37.623 µm, in contrast with the
results obtained at 40ºC which lead to long
needles with larges particle size and particle
size distribution. Therefore the temperature
was fixed at 60ºC.
In CCD particle size analysis required a
natural log transformation so the model
could be better adjusted. Quadratic order for
Anova calculation was selected as
suggested for Design-Expert 9.0.3 software.
Table 4 presents the results of ANOVA for
chosen model in CCD.
The Model F-value of 22.59 implies the
model is significant. There is only a 0.02%
chance that an F-value this large could occur
due to noise. In this case the effects A
(pressure) and B (concentration) are
significant model terms. The "Lack of Fit F-
value" is of 67.91, which implies that the
Lack of Fit is significant. Table 5 resumes
Anova results with predicted and adjusted
values. The "Pred R-Squared" of 0.4497 is
not as close to the "Adj R-Squared" of
0.8925 as one might normally expect; i.e. the
difference is more than 0.2. This may
indicate a large block effect or a possible
problem with the model and/or data. Things
to consider are model reduction, response
transformation, outliers, etc. All empirical
models should be tested by doing
confirmation runs.
Std. Dev. 0.66 R-Squared 0.9338
Mean 2.96 Adj R-Squared 0.8925
C.V. % 22.39 Pred R-Squared 0.4497
PRESS 29.17 Adeq Precision 16.819
"Adeq Precision" measures the signal to
noise ratio. A ratio greater than 4 is
desirable. The obtained ratio of 16.819
indicates an adequate signal. The final
model in terms of factors is presented in
Equation 4, and can be used to estimate
mean particle size progression in the design
space.
𝐿𝑛(𝑀𝑃𝑆) = −24.81728 + 0.39560 ×
𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 − 0.58137 × 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 +
0.014680 × 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 × 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 −
1.34023 × 10−3 × 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒2 − 0.66281 ×
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛2 (𝐸𝑞. 4)
Optimization of the factors can be done
numerically and graphically. Numeric
optimization search in the design space,
using the model created during analysis to
find factor settings that meet the defined
purposes, which in this case was to minimize
mean particle size. A set of 21 solutions
were given so the aim was fulfilled, being the
first solution the one with lower prediction of
mean particle size. Figure 2 represents the
graphical optimization of the created model
with the first solution optimization marked.
Table 4 Anova results for choosen model in CCD calculated by Design-Expert 9.0.3.
Source Sum of Squares
df Coefficient Estimate
Standard Error
F Value p-value Prob > F
Model 49.5131 5 22.5873 0.0002
A-pressure 30.3096 1 2.2476 0.2703 69.1346 0.0000
B-concentration
13.1914 1 - 1.3976 0.2548 30.0890 0.0006
AB 0.5387 1 0.3670 0.3311 1.2288 0.2998
A^2 2.1718 1 - 0.8376 0.3764 4.9537 0.0567
B^2 1.3845 1 - 0.6628 0.3730 3.1580 0.1135
Residual 3.5073 8
Lack of Fit 3.4233 3 67.9122 0.0002
Pure Error 0.0840 5
Cor Total 53.0204 13
Table 5: Resume of Anova results with predicted and adjusted values.
Particles morphologies observed in SEM
photomicrographs, were mainly two: long or
middle needles and small spheres. Figure 3
shows particle SEM images of raw
astaxanthin and processed by SAS. From
the SEM images showed in figure 3 images
A, B and C, it is possible to see the effect of
concentration, particularly in particle
morphology. When concentration of
astaxanthin increased in the organic
solution, particle morphology changed from
long needles like to sphere like particles.
Particle size is also affected due
concentration. However, the significant
effect is observed when comparing different
working pressures. Images D and E shows
the effect of pressure at astaxanthin
concentration in the organ-ic solution of 3
Comparing image C with images D and E it
Design-Expert® SoftwareFactor Coding: ActualOriginal Scaleparticle size (um)
Design points above predicted valueDesign points below predicted value218.578
0.202
X1 = A: pressureX2 = B: concentration
1 1.5 2 2.5 3100 112.5
125 137.5
150
0
50
100
150
200
250
300
pa
rti
cle
siz
e (
um
)
A: pressure (bar)
B: concentration (mg/ml)
0.170896
Figure 2: Graphical representation of created CCD model at 2 factors (Pressure and Concentration) and 1 response (mean particle size). Thelabeled point (0.17) is an estimation of the minimum response that can be obtained from the
given model.
R A B
C D E
Figure 3: SEM images of: Raw Astaxanthin (R); A- Micronization CCD run 1 (1.0 mg/ml); B- CCD Run3 (2.0mg/ml); C- CCD Run7 (3.0mg/ml); D- CCD Run2 (125bar); E- CCD Run11 (150bar).
. Its possible to verify that pressure as a major effect on particle size, being verified that when pressure increased micronized astaxanthin presented larger particle sizemg/ml, 60ºC and 1.5 ml/min of organic solution flow-rate.Particle size measurements were made by Image J software through analysis of SEM images, Mastersize and Nano Particle Analysis (NTA). These methods are complementary in terms of range of size and other constrains. HPLC analysis of the micronized astaxanthin at 60ºC, 100 bar, organic solution concentration of 3mg/ml and solution flow rate of 1.5 ml/min showed that the micronized powder presented a composition of around 100% astaxanthin (relative percentage of pigments obtained from HPLC). It was not observed the presence of other minor or degradation Analysis of the solution collected in the separation vessel, for the SAS experiments carried out in the previously mentioned experimental conditions,products. showed the presence of other pigment.
Astaxathin corresponded only to 72%
(relative percentage obtained from HPLC
chromatograms) of the total pigments in the
solutions. The other pigment present in the
chromatogram, which presented a relative
compostion of 28%, could be a degradation
product or the impurities of the initial
astaxanthin that were concentrated in the
solution leaving the precipitation vessel.
Possibly this impurities are more soluble in
supercritical CO2 than the astaxanthin and
so are dissolved in the flow leaving the high
pressure vessel.
FFD Run 8 and CCD Run 7 were performed
at the same conditions of pressure, 100 bar,
concentration of organic solution, 3.0 mg/ml,
and temperature, 60°C. The only difference
between the experimental conditions of both
runs is the organic solution flow rate, which
was of 0.5ml/min in Run 8 of FFD and
1.5ml/min in Run 7 of CCD. Experimental
design analysis showed insignificant
contribution of the solution flow rate factor in
the astaxanthin micronization process.
However, comparing the particle size
distribution of both runs, it is possible to
verify a small difference between them.
Moreover, SEM images of both runs showed
a slight difference in the morphology of the
particles (Figure 3).
From the Figure 4 it is possible to verify that
for the lower organic solvent flow-rate
particle size presents a narrow particle size
distribution. The combination of these facts
indicates that even if the solution flow rate
has numerically low relevance in the FFD
model, its contribution can be considered
important to obtain a narrow particle size
distribution. These results ilustrate an extra
valorization of solution flow rate, which was
discarded in experimental design. The
images presented in Figure 17 are at the
same amplification, and it can be seen that,
although the morphology was the same for
both organic solution flow rates, sphere-like
particles, the run at the lower organic
Figure 4: SEM images of a sample of micronized astaxanthin at solution flow rate of 0.15ml/min (Run 8 FFD) at the left,
and flow rate of 1.5ml/min (Run 7 CCD) at the right.
solvent flow rate showed smaller particles
with very similar particle size. On the other
hand, when a higher organic solution flow-
rate was used slightly larger particles were
obtained. From Tables 3 and 6 it is possible
to verif a difference of 20 nm between the
two samples
Figure5: Particle size distribution of FFD Run8 and CCD Run7.
Temperature effect, althought also not
considered in CCD, had an expressive effect
in the micronization process. It was found
that a complete different morphology, as
well as smaller particle size could be
obtained at 60°C. A possible reason for this
behaviour is the fact that the rise in
temperature leads to an increase of
astaxanthin solubility in THF and, since the
concentration remains the same, a less
saturated solution is obtained. Astaxanthin
will be more disperse in the solvent and
interaction of organic solvent/ supercritical
anti-solvent occurs and astaxanthin will
precipitate in smaller particles. To a better
visualization of temperature effect, Figure 6
shows the evolution of mean particle size
with this factor. As seen in this figure MPS
decreases with the increase of temperature.
In what concerns the effect of pressure, in
the SAS micronization of astaxanthin, CCD
analysis allowed to obtain the results shown
on Table 6, as well as in the Figure 19. The
point at 100 bar shows that at this pressure
there is a higher probability to find particles
with desirable properties, and increasing this
factor will lead to a larger range of the
particle size. Therefore, higher organic
solution concentration and lower pressure
proved to be the most favorable conditions
for the SAS micronization of astaxanthin.
Figure 6: Graphical representatio6n of mean particle
size evolution with temperature change.
Figure 7 represents the effect of pressure at
60ºC, 1,5 ml/min solvent flow-rate and 3
mg/ml of organic solution concentration (the
same trend was observed for the other
organic solution concentrations studied –
see Table 6). Mean particle size increases
with pressure and particle size distribution
becomes narrower for lower pressures. The
increase of particle size with pressure has
been notice by other authors for SAS of
compounds like beta-carotene or lycopene
(Cocero et al., 2006 and Cocero et al.,
2008).
A possible explanation can be the fact that
the increase in pressure corresponds to a
rise in the density of the supercritical fluid
and consequently the solubility of
astaxanthin increases in CO2 since the
supersaturation decreases leading, to a
decrease in the particle size.
In Figure 8 is shown the influence of organic
solution concentration in the mean particle
size, at 100 bar, 60ºC and 1.5 ml/min of
organic solution flow rate. It can be observed
that the mean particle size decreased with
the increase of astaxanthin concentration in
0
0,002
0,004
0,006
0,008
0 200 400 600 800
%
o
f
P
a
r
t
i
c
l
e
sMean Particle Size (nm)
CCD Run 7
FFD Run 8
0
20
40
60
80
100
38 48 58 68
MP
S (µ
m)
Temperature (°C)
100 bar150 bar
0
50
100
150
50 100 150 200
Mean P
art
icle
Siz
e
(mm
)
Pressure (bar)
Figure 7: Mean particle size of SAS micronized astaxanthin as a function of pressure, at 60ºC, 3 mg/ml and 1.5 ml/min organic solution flow rate.
the organic solution. Larger particles with a
different morphology, similar to needle-like,
were obtained when using the lowest
concentration. When using concentrations of
3 mg/ml, sphere-like particles and lower
mean particle sizes were obtained. A
narrower particle size distribution was also
achieved using 3 mg/ml. This trend possibly
occurs, because, the higher concentration
allows to attain higher supersaturation,
which tends to decrease the particle size.
Conclusion
Yield of micronization obtained for the
experiments with lower particle size was
of approximately 67% for FFD and 50%
for CCD. Conclusion
Micronization of astaxanthin was
successfully done by SAS process. The
lowest particle size found was 0.182 µm at
100 bar, 60°C, 3mg/ml and 0.5mg/ml. in this
experiment (Run8 FFD) was found particle
size with sphere morphology and narrow
particle size distribution ( range of 1.0 µm).
References
Symposium series 406. American Chemical Society,Washington, DC, pp. 334-354.
Guedes, A. C., Amaro, H., & Malcata, F. (2011). Microalgae as Sources of Carotenoids. Mar. Drugs.
Guerin, M., Huntley, M., & Olaizola, M. (2003). Haematococcus astaxanthin:applications for human health and nutrition. TRENDS in Biotechnology.
Hannay, J., & Hogarth, J. (1879). Proc. Roy. Soc. London .
Hong, H. L., Suo, Q., Han, L., & Li, C. (2009). Study on Precipitation of Astaxanthin in Supercritical Fluid. Powder Technology.
HUSSEIN, G., GOTO, H., ODA, S., SANKAWA, U., MATSUMOTO, K., & WATANABE, H. (2006). Antihypertensive Potential and Mechanism of Action of Astaxanthin:IIIAntioxidant and Histopathological Effects in Spontaneously. Biol. Pharm. Bull.
Marco, I. D., Cardea, S., & Reverchon, E. (2013). Polymer Micronization using Batch Supercritical Antisolvent process. CHEMICAL ENGINEERING TRANSACTIONS.
Marco, I. D., & Reverchon, E. (2011). Influence of pressure, temperature and concentration on the mechanisms of particle precipitation in supercritical antisolvent micronization. J. of Supercritical Fluids.
Mattea, F., Martín, Á., & Cocero, M. (2009). Carotenoid processing with supercritical fluids. Journal of Food Engineering.
Mendes, R. L., Nobre, B., Cardoso, M., Ana P. Pereira, A., & Palavra, A. (2003). Supercritical carbon dioxide extraction of compounds with pharmaceutical importance from microalgae. Inorganica Chimica Acta.
Miguel, F., Martín, A., Gamse, T., & Cocero, M. (2006). Supercritical anti solvent precipitation of lycopene Effect of the operating parameters. J. of Supercritical Fluids.
Miguel, F., Martín, A., Mattea, F., & Cocero, M. (2008). Precipitation of lutein and co-precipitation of lutein and poly-lactic acid with the supercritical anti-solvent process. Chemical Engineering and Processing.
Montes, A., Gordillo, M., Pereyra, C., & de la Ossa, E. (2013). Supercritical CO2 precipitation of poly(l-lactic acid) in a wide range of miscibility. J. of Supercritical Fluids.
D
0,0
1,0
2,0
3,0
4,0
5,0
6,0
0 2 4Mean P
art
icle
Siz
e
(mm
)
Organic Solution concentration (mg/ml)
Figure 8: Mean particle size of SAS micronized astaxanthin as a function of organic solution
concentration